ADUS:NGS-Addus HomeCare Corporation (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 113.27

Change

-2.36 (-2.04)%

Market Cap

USD 0.39B

Volume

0.17M
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Addus HomeCare Corp provides home and community based services, which are social in nature and are provided in the home, focused on the dual eligible population.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-28 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

+0.23 (+0.16%)

USD 7.86B
OPCH Option Care Health Inc

+0.52 (+1.64%)

USD 5.14B
AMED Amedisys Inc

+0.33 (+0.35%)

USD 3.13B
PIII P3 Health Partners Inc

-0.18 (-2.44%)

USD 2.88B
SGRY Surgery Partners Inc

-0.09 (-0.37%)

USD 2.84B
ACHC Acadia Healthcare Company Inc

+0.10 (+0.44%)

USD 2.20B
LFST Lifestance Health Group Inc

-0.13 (-2.15%)

USD 2.13B
ASTH Astrana Health Inc

-0.23 (-0.93%)

USD 1.25B
AVAH Aveanna Healthcare Holdings In..

-0.05 (-0.94%)

USD 1.07B
HCSG Healthcare Services Group Inc

+0.15 (+1.07%)

USD 1.06B

ETFs Containing ADUS

SBM 7.23 % 0.95 %

N/A

N/A
SMN ProShares UltraShort Basi.. 7.23 % 0.95 %

-0.09 (-0.32%)

N/A
BASE:CA Evolve Global Materials &.. 5.27 % 0.00 %

+0.04 (+-0.32%)

CAD 0.05B
BASE-B:CA Evolve Global Materials &.. 5.27 % 0.00 %

-0.04 (-0.32%)

CAD 0.08B
JHMA 4.37 % 0.47 %

N/A

N/A
5HEE:F Ossiam Irl Icav - Ossiam .. 4.12 % 0.00 %

-1.04 (-0.32%)

USD 0.03B
5HEE:XETRA Ossiam ESG Low Carbon Shi.. 4.12 % 0.00 %

-1.06 (-0.32%)

USD 0.47B
5HED:XETRA Ossiam ESG Low Carbon Shi.. 4.12 % 0.00 %

-0.38 (-0.32%)

N/A
XLPE:LSE Xtrackers LPX Private Equ.. 3.49 % 0.00 %

-4.00 (-0.32%)

N/A
2B7B:XETRA iShares S&P 500 Materials.. 2.92 % 0.00 %

-0.09 (-0.32%)

USD 0.12B
IMSU:LSE iShares S&P 500 Materials.. 2.90 % 0.00 %

-3.13 (-0.32%)

N/A
IUMS:LSE iShares S&P 500 Materials.. 2.90 % 0.00 %

-0.04 (-0.32%)

USD 0.27B
UYM ProShares Ultra Basic Mat.. 2.62 % 0.95 %

+0.04 (+-0.32%)

N/A
XHS SPDR® S&P Health Care Se.. 2.25 % 0.35 %

+0.12 (+-0.32%)

USD 0.09B
VVAL:LSE 0.54 % 0.00 %

N/A

N/A
VCIT Vanguard Intermediate-Ter.. 0.10 % 0.07 %

+0.28 (+-0.32%)

USD 51.55B
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

+0.03 (+-0.32%)

N/A
VCSH Vanguard Short-Term Corpo.. 0.08 % 0.07 %

+0.12 (+-0.32%)

USD 34.48B
VCLT Vanguard Long-Term Corpor.. 0.07 % 0.07 %

+0.50 (+-0.32%)

USD 13.16B
BIV Vanguard Intermediate-Ter.. 0.05 % 0.07 %

+0.29 (+-0.32%)

N/A
BLV Vanguard Long-Term Bond I.. 0.04 % 0.07 %

+0.52 (+-0.32%)

N/A
BSV Vanguard Short-Term Bond .. 0.02 % 0.07 %

+0.13 (+-0.32%)

N/A
CZA Invesco Zacks Mid-Cap ETF 0.00 % 0.65 %

+0.59 (+-0.32%)

N/A
FMAT Fidelity® MSCI Materials.. 0.00 % 0.08 %

+0.15 (+-0.32%)

N/A
MXI iShares Global Materials .. 0.00 % 0.46 %

+0.34 (+-0.32%)

N/A
VAW Vanguard Materials Index .. 0.00 % 0.10 %

+0.59 (+-0.32%)

N/A
WMCR 0.00 % 0.50 %

N/A

N/A
SXLB:LSE SPDR S&P U.S. Materials S.. 0.00 % 0.00 %

-0.14 (-0.32%)

N/A
ZPDM:XETRA SPDR S&P U.S. Materials S.. 0.00 % 0.00 %

-0.41 (-0.32%)

N/A
SCHI Schwab 5-10 Year Corporat.. 0.00 % 0.00 %

+0.09 (+-0.32%)

USD 8.36B
SIXL 6 Meridian Low Beta Equit.. 0.00 % 0.00 %

+0.09 (+-0.32%)

USD 0.19B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.64% 47% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.64% 47% F 41% F
Trailing 12 Months  
Capital Gain 2.10% 59% D- 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.10% 59% D- 52% F
Trailing 5 Years  
Capital Gain 14.46% 58% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.46% 58% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain 6.01% 61% D- 60% D-
Dividend Return 6.01% 61% D- 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 23.10% 89% A- 70% C-
Risk Adjusted Return 26.01% 75% C 62% D
Market Capitalization 0.39B 72% C 80% B-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 49.30 72% 37%
Price/Book Ratio 2.08 54% 44%
Price / Cash Flow Ratio 17.53 28% 16%
Price/Free Cash Flow Ratio 17.34 33% 21%
Management Effectiveness  
Return on Equity 9.18% 89% 75%
Return on Invested Capital 7.62% 73% 72%
Return on Assets 6.52% 93% 88%
Debt to Equity Ratio 22.51% 56% 55%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector